Navigating the CMS 14-Day Rule in Biomarker Testing

David L. Rimm, MD, PhD; Roy S. Herbst, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Drs. David Rimm and Roy Herbst review the problems with the CMS “14-Day Rule” since some of the multigene panel biomarker tests require 21 days or longer to complete.

Related Videos

September 7, 2018

Healthcare Team’s Relationship to the Patient

Dr Andrey Antov expands on how the healthcare team can work together to provide the best possible care for their patient.

January 10, 2019

Is Immunotherapy Appropriate Here?

Dr Morganna Freeman on the challenge of deciding when to treat a patient with immunotherapy.